PRSS54

gene
On this page

Also known as FLJ25339KLKBL4CT67

Summary

PRSS54 (serine protease 54, HGNC:26336) is a protein-coding gene on chromosome 16q21, encoding Inactive serine protease 54 (Q6PEW0).

This gene encodes a putative serine-type endopeptidase containing the peptidase S1 domain. Alternative splicing of this gene results in multiple transcript variants.

Source: NCBI Gene 221191 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 35 total
  • MANE Select transcript: NM_001305173

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26336
Approved symbolPRSS54
Nameserine protease 54
Location16q21
Locus typegene with protein product
StatusApproved
AliasesFLJ25339, KLKBL4, CT67
Ensembl geneENSG00000103023
Ensembl biotypeprotein_coding
Entrez221191

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 5 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000219301, ENST00000543437, ENST00000563336, ENST00000567164, ENST00000569079, ENST00000569727

RefSeq mRNA: 3 — MANE Select: NM_001305173 NM_001080492, NM_001305173, NM_001305174

CCDS: CCDS32463, CCDS76882

Canonical transcript exons

ENST00000567164 — 7 exons

ExonStartEnd
ENSE000006867515828459058284721
ENSE000012987815827999758280757
ENSE000015041185829095958291136
ENSE000025795155829398558294209
ENSE000026204995829488758295025
ENSE000034984765828593758286195
ENSE000035428235829373258293822

Expression profiles

Bgee: expression breadth broad, 80 present calls, max score 91.11.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0565 / max 54.1302, expressed in 4 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
1576140.03793
1576150.00863
2079020.00594
1576130.00423

Top tissues by expression

223 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453391.11gold quality
spermCL:000001990.83gold quality
right testisUBERON:000453490.82gold quality
testisUBERON:000047388.52gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047381.64silver quality
adult organismUBERON:000702372.64gold quality
buccal mucosa cellCL:000233665.57gold quality
medial globus pallidusUBERON:000247761.55silver quality
oviduct epitheliumUBERON:000480461.46silver quality
tibiaUBERON:000097958.70silver quality
globus pallidusUBERON:000187557.02silver quality
cartilage tissueUBERON:000241855.66gold quality
tendon of biceps brachiiUBERON:000818855.06gold quality
cardiac muscle of right atriumUBERON:000337954.34gold quality
left ventricle myocardiumUBERON:000656654.23gold quality
kidney epitheliumUBERON:000481953.93gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099153.76gold quality
epithelial cell of pancreasCL:000008353.59gold quality
upper arm skinUBERON:000426353.52gold quality
tibialis anteriorUBERON:000138551.71silver quality
ileal mucosaUBERON:000033151.26silver quality
pancreatic ductal cellCL:000207951.23silver quality
myocardiumUBERON:000234950.25gold quality
deltoidUBERON:000147650.12gold quality
nasal cavity epitheliumUBERON:000538447.03gold quality
quadriceps femorisUBERON:000137746.59gold quality
fallopian tubeUBERON:000388946.03gold quality
prefrontal cortexUBERON:000045145.61gold quality
vastus lateralisUBERON:000137945.40gold quality
upper leg skinUBERON:000426245.25silver quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.13

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

17 targeting PRSS54, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-513B-5P99.9969.962150
HSA-MIR-132399.8369.892471
HSA-MIR-92A-2-5P99.7567.012164
HSA-MIR-3913-3P99.7466.53938
HSA-MIR-7157-5P99.6669.331829
HSA-MIR-431099.5968.842527
HSA-MIR-432899.5771.064094
HSA-MIR-6731-5P99.2867.422375
HSA-MIR-808599.2867.562362
HSA-MIR-6873-5P98.4566.141417
HSA-MIR-338-3P98.1467.381137
HSA-MIR-4797-3P97.4867.14989
HSA-MIR-5000-5P97.4066.111055
HSA-MIR-514A-3P96.4367.771048
HSA-MIR-514B-3P96.4367.771048
HSA-MIR-6858-3P96.3764.41771
HSA-MIR-426496.3564.761480

Literature-anchored findings (GeneRIF, showing 1)

  • Testis-specific serine protease PRSS54 regulates acrosomal granule localization and sperm head morphogenesis in micedagger. (PMID:35863763)

Cross-species orthologs

13 orthologs

OrganismSymbolGene ID
mus_musculusPrss54ENSMUSG00000048400
rattus_norvegicusPrss54ENSRNOG00000023092
drosophila_melanogasterCG9673FBGN0030775
drosophila_melanogasterCG4477FBGN0035971
drosophila_melanogasterCG17404FBGN0038001
drosophila_melanogasterCG12256FBGN0038002
drosophila_melanogasterCG3916FBGN0038003
drosophila_melanogasterCG17477FBGN0038479
drosophila_melanogasterCG4053FBGN0038482
drosophila_melanogasterCG31269FBGN0051269
drosophila_melanogasterCG32808FBGN0052808
drosophila_melanogasterPhae2FBGN0263235
drosophila_melanogasterSend2FBGN0264253

Paralogs (12): KLK14 (ENSG00000129437), KLK8 (ENSG00000129455), TMPRSS4 (ENSG00000137648), KLK3 (ENSG00000142515), KLK1 (ENSG00000167748), KLK4 (ENSG00000167749), KLK2 (ENSG00000167751), KLK5 (ENSG00000167754), KLK11 (ENSG00000167757), KLK7 (ENSG00000169035), KLK12 (ENSG00000186474), PRSS58 (ENSG00000258223)

Protein

Protein identifiers

Inactive serine protease 54Q6PEW0 (reviewed: Q6PEW0)

Alternative names: Cancer/testis antigen 67, Plasma kallikrein-like protein 4

All UniProt accessions (5): Q6PEW0, A0A140VKC3, F5H6C6, H3BNY0, H3BQS7

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Secreted.

Similarity. Belongs to the peptidase S1 family. Plasma kallikrein subfamily.

RefSeq proteins (3): NP_001073961, NP_001292102, NP_001292103 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001254Trypsin_domDomain
IPR009003Peptidase_S1_PAHomologous_superfamily
IPR043504

Pfam: PF00089

UniProt features (13 total): sequence variant 3, disulfide bond 3, glycosylation site 2, signal peptide 1, chain 1, domain 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6PEW0-F167.530.34

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Disulfide bonds (3): 164–227, 195–205, 217–248

Glycosylation sites (2): 123, 327

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 24 (showing top): chr16q21, GOBP_PROTEOLYSIS, GOMF_PEPTIDASE_ACTIVITY, ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP, MIR4310, MIR6858_3P, DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS, DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS, GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP, GOMF_SERINE_HYDROLASE_ACTIVITY, GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP, GSE7460_TREG_VS_TCONV_ACT_DN, GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP, GOMF_ENDOPEPTIDASE_ACTIVITY, GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN

GO Biological Process (1): proteolysis (GO:0006508)

GO Molecular Function (1): serine-type endopeptidase activity (GO:0004252)

GO Cellular Component (2): obsolete extracellular space (GO:0005615), extracellular region (GO:0005576)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
protein metabolic process1
endopeptidase activity1
serine-type peptidase activity1
cellular anatomical structure1

Protein interactions and networks

STRING

340 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
PRSS54PRSS37A4D1T9643
PRSS54TEX55Q96M34643
PRSS54OR5C1Q8NGR4598
PRSS54SPMAP2Q9P2T0571
PRSS54CT62P0C5K7541
PRSS54SPATA46Q5T0L3507
PRSS54C1orf167Q5SNV9479
PRSS54CPXCR1Q8N123479
PRSS54SPMIP9Q96LM6479
PRSS54OR4X1Q8NH49452
PRSS54PASD1Q8IV76447
PRSS54RBM46Q8TBY0418
PRSS54GPR25O00155414
PRSS54OR7C2O60412400
PRSS54ADAM29Q9UKF5397

IntAct

0 interactions, top by confidence:

ESM2 similar proteins: A0A1B0GVH4, A1L453, A4D1T9, A6H6T1, A8MTI9, A8QL53, A8QL57, B5U6Y3, E5RG02, O35453, O70169, P00745, P04070, P08709, P0CG03, P0DJE9, P22891, Q14BX2, Q28278, Q28661, Q2F9P2, Q2F9P4, Q2TV78, Q3V0Q7, Q402U7, Q4R7Y7, Q5FBW1, Q5M8S2, Q6AXZ6, Q6AY28, Q6IE62, Q6IE63, Q6PEW0, Q6UWB4, Q76HL1, Q7M756, Q7M761, Q7RTY5, Q7RTY7, Q7Z5A4

Diamond homologs: Q6AY28, Q6PEW0, Q6UWB4, Q7M756, Q2KJ63, E5AJX2, P03951, P03952, Q5NTB3, Q91Y47

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

35 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance28
Likely benign4
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

1247 predictions. Top by Δscore:

VariantEffectΔscore
16:58284728:CA:Cacceptor_gain1.0000
16:58284729:A:ACacceptor_gain1.0000
16:58284729:A:Cacceptor_gain1.0000
16:58285935:A:Cdonor_gain1.0000
16:58293626:C:Adonor_gain1.0000
16:58280754:CCCC:Cacceptor_gain0.9900
16:58280755:CCC:Cacceptor_gain0.9900
16:58280755:CCCC:Cacceptor_gain0.9900
16:58280756:CC:Cacceptor_gain0.9900
16:58280756:CCC:Cacceptor_gain0.9900
16:58280756:CCCTG:Cacceptor_loss0.9900
16:58280757:CC:Cacceptor_gain0.9900
16:58280758:C:CCacceptor_gain0.9900
16:58280759:T:Cacceptor_loss0.9900
16:58284566:G:Cdonor_gain0.9900
16:58284727:CCA:Cacceptor_gain0.9900
16:58285955:T:TAdonor_gain0.9900
16:58293730:A:ACdonor_gain0.9900
16:58293731:C:CCdonor_gain0.9900
16:58280753:TCCCC:Tacceptor_gain0.9800
16:58280754:CCCCC:Cacceptor_gain0.9800
16:58284718:CTGT:Cacceptor_gain0.9800
16:58284729:A:Tacceptor_gain0.9800
16:58294798:CAGAG:Cdonor_gain0.9800
16:58294799:A:ACdonor_gain0.9800
16:58294799:AGAGA:Adonor_gain0.9800
16:58294800:G:Cdonor_gain0.9800
16:58294898:CATG:Cdonor_gain0.9800
16:58294899:ATGA:Adonor_gain0.9800
16:58280760:G:GCacceptor_gain0.9700

AlphaMissense

2612 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
16:58290982:G:CS80R0.997
16:58290982:G:TS80R0.997
16:58290984:T:GS80R0.997
16:58285952:C:AW169C0.996
16:58285952:C:GW169C0.996
16:58280623:C:AW263C0.994
16:58280623:C:GW263C0.994
16:58286068:C:GA131P0.993
16:58285954:A:GW169R0.992
16:58285954:A:TW169R0.992
16:58291050:A:GS58P0.992
16:58286061:A:GL133P0.991
16:58286096:A:CF121L0.991
16:58286096:A:TF121L0.991
16:58286098:A:GF121L0.991
16:58286067:G:TA131D0.990
16:58280625:A:GW263R0.989
16:58280625:A:TW263R0.989
16:58286064:A:GL132P0.989
16:58280732:C:GC227S0.988
16:58280733:A:TC227S0.988
16:58286072:G:CN129K0.987
16:58286072:G:TN129K0.987
16:58291059:A:GW55R0.987
16:58291059:A:TW55R0.987
16:58285967:G:CC164W0.985
16:58291013:C:TG70D0.985
16:58291043:T:GQ60P0.985
16:58280733:A:GC227R0.983
16:58285968:C:GC164S0.982

dbSNP variants (sampled 300 via entrez): RS1000003641 (16:58280355 G>A), RS1000032484 (16:58295691 C>T), RS1000075756 (16:58280128 G>A,T), RS1000156624 (16:58290058 T>A), RS1000294649 (16:58293043 A>G,T), RS1000451091 (16:58286932 A>G), RS1000829508 (16:58287173 T>A), RS1001054161 (16:58281865 C>G), RS1001190895 (16:58294403 T>G), RS1001321074 (16:58286468 T>C), RS1001422959 (16:58293747 G>A), RS1002056437 (16:58283439 A>G), RS1002209588 (16:58295337 A>G), RS1002314647 (16:58289319 G>A), RS1002459544 (16:58289581 T>TTC)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST003121_9Alcohol dependence5.000000e-06
GCST003155_34Systemic lupus erythematosus4.000000e-06

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

6 total (human), top 6 by PubMed support.

ChemicalActions (top 5)PubMed papers
FR900359affects phosphorylation1
bisphenol Aincreases expression1
CGP 52608affects binding, increases reaction1
Resveratrolaffects cotreatment, decreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Valproic Acidincreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): alcohol dependence